Studies utilizing gene knockout and pharmacologic inhibition have demonstrated that the Rheb/mTORC1/S6K/c-myc pathway plays a crucial role in T-ALL tumor growth, promoting tumor cell survival and proliferation (26, 27). The gene discussed is RPS6KB1; the disease is neoplasm.